Table 3 Pregnancy and cumulative outcomes of the CC cotreatment group and GnRHa group after propensity score matching.

From: The cumulative live birth rate and cost-effectiveness of the clomiphene and gonadotropin cotreatment protocol versus the mid-luteal GnRH agonist protocol in women over 35 years old

Characteristic

CC cotreatment group

GnRHa group

p value

Risk ratio (95% CI)

Patients, n

375

375

 

Total no. of patients who underwent embryo transfer

321

336

 

Total no. of embryos transferred

579

821

Total no. of transfer cycles

445

565

Cycle type of embryo transfer, n (%)

 Fresh embryo transfer

217

 

 Frozen embryo transfer

445

348

Stage of embryo transferred, n (%)

 Day 3 embryo transfer

23 (3.97)

376 (45.80)

< 0.001

0.05 (0.03–0.08)

 Blastocyst transfer

556 (96.03)

445 (54.20)

No. of embryos transferred, n (%)

 1

311 (69.89)

309 (54.69)

< 0.001

1.92 (1.48–2.50)

 2

134 (30.11)

256 (45.31)

Implantation rate, %(n)

45.42 (263/579)

39.46 (324/821)

0.028

1.27 (10.3–1.58)

Clinical pregnancy rate per transfer cycle, %(n)

52.36 (233/445)

46.02 (260/565)

0.045

1.29 (1.01–1.65)

Multiple birth rate, %(n)

17.17 (40/233)

16.92 (44/260)

0.943

1.02 (0.64–1.63)

Miscarriage rate, %(n)

29.61 (69/233)

33.85 (88/260)

0.314

0.82 (0.56–1.20)

Ectopic pregnancy rate, %(n)

0.43 (1/233)

0.77 (2/260)

1.000

0.56 (0.05–6.17)

Cumulative biochemical pregnancy rate per initial cycle, %(n)

60.00 (225/375)

68.80 (258/375)

0.015

0.68 (0.50–0.92)

Cumulative clinical pregnancy rate per initial cycle, %(n)

51.73 (194/375)

60.27 (226/375)

0.019

0.71 (0.53–0.94)

CLBR per initial cycle, %(n)

41.07 (154/375)

45.33 (170/375)

0.238

0.84 (0.63–1.12)

Preterm birth rate, %(n)

8.44 (13/154)

14.71 (25/170)

0.080

0.54 (0.26–1.09)

Average birth weight

3300 (2973, 3550)

3280 (2650, 3600)

0.143

Average gestational age at birth

38 (38, 39)

38 (37, 39)

0.005

Congenital malformation rates

0

0

1.000

TTLB

360 (315.8, 445)

326.5 (257.5, 436)

< 0.001

  1. Data are presented as the median (25th and 75th percentile) or number (%). Mann‒Whitney U tests were used for continuous variables, and chi-square tests were used for categorical variables.
  2. CC cotreatment clomiphene citrate and gonadotropin cotreatment, GnRHa gonadotropin-releasing hormone agonist, CI confidence interval, CLBR cumulative live birth rate, TTLB time to first live birth.